2025 Q4 -tulosraportti
Vain PDF
9 päivää sitten
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 316 | - | - | ||
| 231 | - | - | ||
| 415 | - | - | ||
| 283 | - | - | ||
| 1 092 | - | - |
Ylin
15,58VWAP
Alin
14,24VaihtoMäärä
27,4 1 865 810
VWAP
Ylin
15,58Alin
14,24VaihtoMäärä
27,4 1 865 810
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 27.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 päivä sittenGetting so tired of these pretentious amateurs, who mostly seem to compete about who "is right".
·22 t sitten · MuokattuNow I'm not entirely sure who you're referring to, but looking back at the last few days, it must be me, Flemming1, Justice for all, 6Perth, Guldhammer, LP90, Eftertanke or Rosen112. The latter has liked your post, so he/she/it/they probably don't feel "hit" by your comment. I am a happy amateur - though not a prestigious one of its kind - so I can feel a bit offended - especially since I am the type who isn't afraid to stick my neck out and put myself in a vulnerable position. However, I don't think I quite understand your amateurish approach to listening to other people's opinions. This is Nordnet - we are ALL amateurs - otherwise we would be in a larger bank's private banking department - and even though I've been offered that in my own, I am far too small for it to be anything other than a fee machine for my bank. So try to be a bit open-minded - personally, I get great pleasure and joy from reading others' opinions, as long as it happens on a "mature", serious and reasonably well-argued basis. I think I find it very difficult to see what you want with such a post here on a Friday afternoon on a platform that is plastered with happy amateur investors - myself included. Have a good weekend - and feel free to mute me if I am TOO annoying, TOO prestigious or TOO amateurish :-). As a full-blown serious and professional investor, you have obviously strayed into a flock of amateurs - and that is also a bit "træls".
·2 päivää sittenShort 1,06 % it rises
·1 päivä sittenSorry - it was not the intention to belittle or write at a low level. I "enjoy" reading your posts, and it's good to have more eyes. I'll tone down the rhetoric :) But what is it they need to show first, which they haven't done with acadia and jazz? And does it make sense to wait to buy a stock UNTIL they have proven something, and then miss out on the price increase? It's the potential we're buying now. And I don't think the potential is reflected in the price right now at all. I don't think the risk is THAT big... They have after all many horses to ride on! And more in their library that we don't even know/haven't named yet.·1 päivä sitten · MuokattuThat they can handle the new very high risk profile with 3 preclinical projects they have chosen to start in Phase I at the same time. And for me, in biotech, it makes a LOT of sense to wait - it's all a risk/reward analysis. Before the agreements, they were at a price of 2-4 - lots of potential - but high risk. Then they get the agreements - still great potential - but now cash in hand. Price 11-12 - new agreements and new projects - still great potential but less risk - 25-30. The potential may have always been a price of 200+ - and price vs potential then reflects the risk/reward-ratio one is comfortable with. And here some are fine with 25-30 now - I am not. We probably see the same potential - so it's the risk we value differently - I would give 12-15 for that potential with the current risk - others have been willing to give 25-30 for the same potential. They need a lot of money until 2030 and as I have written in another post, I think they will need more than the USD 90-100 mill they themselves have announced - and I also don't think they can get it covered entirely with milestones and new projects. Another Jazz-like sale will naturally help with that, but it's far from enough. There will be a long time between the upcoming fairly certain milestones on their agreements and the next one - and still a risk that partner projects will be stopped. Saniona has been going for many many years - but they still haven't had a product brought to market that today gives them ongoing royalty - that is concerning regarding the assessment of the total validity of their projects regarding whether they are able to find something strong enough to go all the way. They have had a couple of nice spinouts and recently some good deals - but for me, more is needed. And that is the risk I clearly see differently than most other Saniona shareholders. And thanks for clarifying the tone :-). Have a good weekend.- ·2 päivää sittenDoes it look like a shorter day? Then it would be nice if we could refrain from selling!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
9 päivää sitten
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenGetting so tired of these pretentious amateurs, who mostly seem to compete about who "is right".·22 t sitten · MuokattuNow I'm not entirely sure who you're referring to, but looking back at the last few days, it must be me, Flemming1, Justice for all, 6Perth, Guldhammer, LP90, Eftertanke or Rosen112. The latter has liked your post, so he/she/it/they probably don't feel "hit" by your comment. I am a happy amateur - though not a prestigious one of its kind - so I can feel a bit offended - especially since I am the type who isn't afraid to stick my neck out and put myself in a vulnerable position. However, I don't think I quite understand your amateurish approach to listening to other people's opinions. This is Nordnet - we are ALL amateurs - otherwise we would be in a larger bank's private banking department - and even though I've been offered that in my own, I am far too small for it to be anything other than a fee machine for my bank. So try to be a bit open-minded - personally, I get great pleasure and joy from reading others' opinions, as long as it happens on a "mature", serious and reasonably well-argued basis. I think I find it very difficult to see what you want with such a post here on a Friday afternoon on a platform that is plastered with happy amateur investors - myself included. Have a good weekend - and feel free to mute me if I am TOO annoying, TOO prestigious or TOO amateurish :-). As a full-blown serious and professional investor, you have obviously strayed into a flock of amateurs - and that is also a bit "træls".
- ·2 päivää sittenShort 1,06 % it rises·1 päivä sittenSorry - it was not the intention to belittle or write at a low level. I "enjoy" reading your posts, and it's good to have more eyes. I'll tone down the rhetoric :) But what is it they need to show first, which they haven't done with acadia and jazz? And does it make sense to wait to buy a stock UNTIL they have proven something, and then miss out on the price increase? It's the potential we're buying now. And I don't think the potential is reflected in the price right now at all. I don't think the risk is THAT big... They have after all many horses to ride on! And more in their library that we don't even know/haven't named yet.·1 päivä sitten · MuokattuThat they can handle the new very high risk profile with 3 preclinical projects they have chosen to start in Phase I at the same time. And for me, in biotech, it makes a LOT of sense to wait - it's all a risk/reward analysis. Before the agreements, they were at a price of 2-4 - lots of potential - but high risk. Then they get the agreements - still great potential - but now cash in hand. Price 11-12 - new agreements and new projects - still great potential but less risk - 25-30. The potential may have always been a price of 200+ - and price vs potential then reflects the risk/reward-ratio one is comfortable with. And here some are fine with 25-30 now - I am not. We probably see the same potential - so it's the risk we value differently - I would give 12-15 for that potential with the current risk - others have been willing to give 25-30 for the same potential. They need a lot of money until 2030 and as I have written in another post, I think they will need more than the USD 90-100 mill they themselves have announced - and I also don't think they can get it covered entirely with milestones and new projects. Another Jazz-like sale will naturally help with that, but it's far from enough. There will be a long time between the upcoming fairly certain milestones on their agreements and the next one - and still a risk that partner projects will be stopped. Saniona has been going for many many years - but they still haven't had a product brought to market that today gives them ongoing royalty - that is concerning regarding the assessment of the total validity of their projects regarding whether they are able to find something strong enough to go all the way. They have had a couple of nice spinouts and recently some good deals - but for me, more is needed. And that is the risk I clearly see differently than most other Saniona shareholders. And thanks for clarifying the tone :-). Have a good weekend.
- ·2 päivää sittenDoes it look like a shorter day? Then it would be nice if we could refrain from selling!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 316 | - | - | ||
| 231 | - | - | ||
| 415 | - | - | ||
| 283 | - | - | ||
| 1 092 | - | - |
Ylin
15,58VWAP
Alin
14,24VaihtoMäärä
27,4 1 865 810
VWAP
Ylin
15,58Alin
14,24VaihtoMäärä
27,4 1 865 810
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 27.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
2025 Q4 -tulosraportti
Vain PDF
9 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 27.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 28.5.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
0,0823 SEK/osake
Viimeisin osinko
0,00%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 päivä sittenGetting so tired of these pretentious amateurs, who mostly seem to compete about who "is right".·22 t sitten · MuokattuNow I'm not entirely sure who you're referring to, but looking back at the last few days, it must be me, Flemming1, Justice for all, 6Perth, Guldhammer, LP90, Eftertanke or Rosen112. The latter has liked your post, so he/she/it/they probably don't feel "hit" by your comment. I am a happy amateur - though not a prestigious one of its kind - so I can feel a bit offended - especially since I am the type who isn't afraid to stick my neck out and put myself in a vulnerable position. However, I don't think I quite understand your amateurish approach to listening to other people's opinions. This is Nordnet - we are ALL amateurs - otherwise we would be in a larger bank's private banking department - and even though I've been offered that in my own, I am far too small for it to be anything other than a fee machine for my bank. So try to be a bit open-minded - personally, I get great pleasure and joy from reading others' opinions, as long as it happens on a "mature", serious and reasonably well-argued basis. I think I find it very difficult to see what you want with such a post here on a Friday afternoon on a platform that is plastered with happy amateur investors - myself included. Have a good weekend - and feel free to mute me if I am TOO annoying, TOO prestigious or TOO amateurish :-). As a full-blown serious and professional investor, you have obviously strayed into a flock of amateurs - and that is also a bit "træls".
- ·2 päivää sittenShort 1,06 % it rises·1 päivä sittenSorry - it was not the intention to belittle or write at a low level. I "enjoy" reading your posts, and it's good to have more eyes. I'll tone down the rhetoric :) But what is it they need to show first, which they haven't done with acadia and jazz? And does it make sense to wait to buy a stock UNTIL they have proven something, and then miss out on the price increase? It's the potential we're buying now. And I don't think the potential is reflected in the price right now at all. I don't think the risk is THAT big... They have after all many horses to ride on! And more in their library that we don't even know/haven't named yet.·1 päivä sitten · MuokattuThat they can handle the new very high risk profile with 3 preclinical projects they have chosen to start in Phase I at the same time. And for me, in biotech, it makes a LOT of sense to wait - it's all a risk/reward analysis. Before the agreements, they were at a price of 2-4 - lots of potential - but high risk. Then they get the agreements - still great potential - but now cash in hand. Price 11-12 - new agreements and new projects - still great potential but less risk - 25-30. The potential may have always been a price of 200+ - and price vs potential then reflects the risk/reward-ratio one is comfortable with. And here some are fine with 25-30 now - I am not. We probably see the same potential - so it's the risk we value differently - I would give 12-15 for that potential with the current risk - others have been willing to give 25-30 for the same potential. They need a lot of money until 2030 and as I have written in another post, I think they will need more than the USD 90-100 mill they themselves have announced - and I also don't think they can get it covered entirely with milestones and new projects. Another Jazz-like sale will naturally help with that, but it's far from enough. There will be a long time between the upcoming fairly certain milestones on their agreements and the next one - and still a risk that partner projects will be stopped. Saniona has been going for many many years - but they still haven't had a product brought to market that today gives them ongoing royalty - that is concerning regarding the assessment of the total validity of their projects regarding whether they are able to find something strong enough to go all the way. They have had a couple of nice spinouts and recently some good deals - but for me, more is needed. And that is the risk I clearly see differently than most other Saniona shareholders. And thanks for clarifying the tone :-). Have a good weekend.
- ·2 päivää sittenDoes it look like a shorter day? Then it would be nice if we could refrain from selling!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 316 | - | - | ||
| 231 | - | - | ||
| 415 | - | - | ||
| 283 | - | - | ||
| 1 092 | - | - |
Ylin
15,58VWAP
Alin
14,24VaihtoMäärä
27,4 1 865 810
VWAP
Ylin
15,58Alin
14,24VaihtoMäärä
27,4 1 865 810
Välittäjätilasto
Dataa ei löytynyt